Sofia Martin-Suarez1, Gregorio Gliozzi1, Mariafrancesca Fiorentino1, Antonio Loforte1, Valentina Ghigi2, Marcello Di Camillo3, Nazareno Galiè4, Davide Pacini1. 1. Cardiac Surgery Department, Pulmonary Hypertension Unit, Bologna University, St. Orsola Hospital, Bologna, Italy. 2. Cardiac Surgery Anesthesia Department, Pulmonary Hypertension Unit, Bologna University, St. Orsola Hospital, Bologna, Italy. 3. Clinical Perfusionist, Pulmonary Hypertension Unit, Bologna University, St. Orsola Hospital, Bologna, Italy. 4. Cardiology Department, Pulmonary Hypertension Unit, Bologna University, St. Orsola Hospital, Bologna, Italy.
Abstract
BACKGROUND: Pulmonary endarterectomy (PEA) is a surgical intervention reserved for patients with chronic thromboembolic pulmonary hypertension (CTEPH). In some cases, temporary circulatory support [extracorporeal life support (ECLS)] is required after PEA. Rates of ECLS requirement varies between centers. Reasons for institution of ECLS include respiratory failure, cardiac failure (or both respiratory and cardiac failure), bleeding, and reperfusion edema. This article reviews the experience of ECLS after PEA from the current literature, as well as our own institution's experience as a CTEPH multidisciplinary center. METHODS: A literature review was conducted along with a retrospective chart review from 15 years of our PEA program. RESULTS: The literature demonstrates many different approaches are used for mechanically supporting patients who develop complications after PEA. Variations in approach stem from differing indications such as, respiratory failure rather than hemodynamic compromise (or vice versa), time of implantation (immediately in operating room or delayed after surgery) and many other causes. In our center, 12.3% (19/154) of patients need ECLS with extracorporeal membrane oxygenator (ECMO) after PEA procedure. Implantation was mainly in the operating room before or immediately after weaning from cardiopulmonary bypass and mostly peripheral cannulation was used. ECMO lasted an average of 11±8 days. And 52.6% (10 of 19 patients) of patients were weaned from ECLS and of this, 70% (7 of 10 patients) were discharged. CONCLUSIONS: In some cases of PEA, ECLS is needed post-operatively. Expert teams should consider this possibility pre-operatively based on predisposing characteristics. The need for ECMO shouldn't be "di per se" a contraindication to surgery but might be considered in the surgical risk estimation. The ideal setup is not fixed and depends on the center's practices as well as indication. Even though complications do occur with ECMO, in general, results are good, being a bridge to further recovery of pulmonary hypertension (PH) or also to transplantation.
BACKGROUND: Pulmonary endarterectomy (PEA) is a surgical intervention reserved for patients with chronic thromboembolic pulmonary hypertension (CTEPH). In some cases, temporary circulatory support [extracorporeal life support (ECLS)] is required after PEA. Rates of ECLS requirement varies between centers. Reasons for institution of ECLS include respiratory failure, cardiac failure (or both respiratory and cardiac failure), bleeding, and reperfusion edema. This article reviews the experience of ECLS after PEA from the current literature, as well as our own institution's experience as a CTEPH multidisciplinary center. METHODS: A literature review was conducted along with a retrospective chart review from 15 years of our PEA program. RESULTS: The literature demonstrates many different approaches are used for mechanically supporting patients who develop complications after PEA. Variations in approach stem from differing indications such as, respiratory failure rather than hemodynamic compromise (or vice versa), time of implantation (immediately in operating room or delayed after surgery) and many other causes. In our center, 12.3% (19/154) of patients need ECLS with extracorporeal membrane oxygenator (ECMO) after PEA procedure. Implantation was mainly in the operating room before or immediately after weaning from cardiopulmonary bypass and mostly peripheral cannulation was used. ECMO lasted an average of 11±8 days. And 52.6% (10 of 19 patients) of patients were weaned from ECLS and of this, 70% (7 of 10 patients) were discharged. CONCLUSIONS: In some cases of PEA, ECLS is needed post-operatively. Expert teams should consider this possibility pre-operatively based on predisposing characteristics. The need for ECMO shouldn't be "di per se" a contraindication to surgery but might be considered in the surgical risk estimation. The ideal setup is not fixed and depends on the center's practices as well as indication. Even though complications do occur with ECMO, in general, results are good, being a bridge to further recovery of pulmonary hypertension (PH) or also to transplantation.
Authors: Gerard R Manecke; Andreas Kotzur; Gus Atkins; Peter F Fedullo; William R Auger; David P Kapelanski; Stuart W Jamieson Journal: Anesth Analg Date: 2004-09 Impact factor: 5.108
Authors: Patricia A Thistlethwaite; Michael M Madani; Aaron D Kemp; Mary Hartley; William R Auger; Stuart W Jamieson Journal: Ann Thorac Surg Date: 2006-12 Impact factor: 4.330
Authors: Marius Berman; Steven Tsui; Alain Vuylsteke; Andrew Snell; Simon Colah; Ray Latimer; Roger Hall; Joseph E Arrowsmith; John Kneeshaw; Andrew A Klein; David P Jenkins Journal: Ann Thorac Surg Date: 2008-10 Impact factor: 4.330
Authors: Marco Morsolini; Andrea Azzaretti; Giulio Orlandoni; Andrea M D'Armini Journal: J Thorac Cardiovasc Surg Date: 2013-01-09 Impact factor: 5.209
Authors: Antonio Loforte; Giuseppe Comentale; Gregorio Gliozzi; Giulio Giovanni Cavalli; Davide Pacini; Sofia Martin-Suarez Journal: Ann Cardiothorac Surg Date: 2022-03
Authors: Sofia Martin-Suarez; Giulio Giovanni Cavalli; Gregorio Gliozzi; Carlo Mariani; Antonio Loforte; Davide Pacini Journal: Ann Cardiothorac Surg Date: 2022-03